MedTrace Logo

Prevalence of Thyroid Dysfunction and Anti-thyroid Antibodies in Infertile Women

NCT03964779 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-05-28

No results posted yet for this study

Summary

The study population will be divided into three groups:

* Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,
* Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and
* Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.

. All women will be subjected to:
* Informed consent
* Full history taking, including age, duration of infertility and whether primary or secondary
* General and pelvix examination
* Trans-vaginal ultrasonography
* Determination of hormonal profile (FSH, LH, Estradiol, Prolactin)
* Determination of ovulatory status
* Determination of of tubal patency
* Determination of presence of male factor
* Determination of TSH and antithyroid antibodies (antithyroglobulin and antithyroid peroxidase) blood levels

Conditions

  • Infertility, Female

Interventions

DIAGNOSTIC_TEST

Hormonal assay

Measurement of Thyroid stimulating hormone

DIAGNOSTIC_TEST

Antibody assay

antithyroglobulin and antithyroid peroxidase

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Maged · Professor

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-31
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03964779 on ClinicalTrials.gov